Phantom A.i.d.s. Fear Hits Britain (Press, 9 August 1988)

A report published in the “Journal of the Royal College of Physicians” in London addresses the troubling phenomenon where individuals who believe they have acquired immunodeficiency syndrome (AIDS) are experiencing phantom symptoms that significantly impact their mental and physical well-being. This issue appears to be rising among psychologically vulnerable individuals who are leveraging the AIDS pandemic as an avenue to express their underlying sexual, psychological, or psychiatric vulnerabilities. The report highlights specific cases demonstrating this trend. One particular case involves a woman who had sexual relations with two men and, fearing she had transmitted the virus to one, began to exhibit symptoms akin to those of AIDS, including swollen glands and night sweats, despite her blood tests returning negative. Another case describes a professional man who, after receiving three negative blood test results, fixated on the fear of having contracted the HIV virus during a casual encounter. His anxiety over potentially infecting his girlfriend led to a postponement of their plans to start a family. Alarmingly, the report indicates that over half of the patients with such symptoms had considered suicide to escape the distress they associate with the impending diagnosis of AIDS. The report also presents a glimmer of hope through therapeutic intervention, noting that psychotherapy designed to help patients reframe their symptoms as linked to anxiety rather than HIV has resulted in significant improvements in their conditions. In a related matter, the British Medical Association (BMA) has raised concerns regarding the practice of conducting AIDS-related tests by doctors for insurance companies without the patient's informed consent. They are urging the Association of British Insurers to retract its recent guidance on HIV testing, following complaints from medical professionals who feel pressured to conduct these tests without proper patient approval. The BMA is worried that this could lead to patients discovering their condition only through an insurance notification, underscoring the ethical implications surrounding consent and patient confidentiality in the context of HIV testing.

The text on this page is created, in the most part, using Generative AI and so may contain errors or omissions. It is supplied to you without guarantee or warranty of correctness. If you find an error or would like to make a content suggestion please get in contact

The text on this page is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand